Literature DB >> 3104660

Selective removal of low density lipoproteins (LDL) by precipitation at low pH: first clinical application of the HELP system.

T Eisenhauer, V W Armstrong, H Wieland, C Fuchs, F Scheler, D Seidel.   

Abstract

The first clinical application of a new extracorporeal procedure (HELP) for the selective elimination of low-density lipoproteins by heparin precipitation at acid pH is described. Plasma, obtained by filtration of whole blood through a 0.2 mu filter, is continuously mixed with an equal volume of an acetate buffer (pH 4.85) containing heparin. After removal of the precipitated heparin complex by filtration, excess heparin is adsorbed to a specially developed filter and the clear plasma filtrate is subject to bicarbonate dialysis/ultrafiltration to restore physiologic pH and remove excess fluid. The calculated efficiency for the elimination of low-density lipoproteins from plasma by HELP is 100% and is therefore comparable to conventional plasmapheresis. The HELP system shows a high degree of specificity with over 80% of total protein being returned to the patient. Over 130 treatment procedures have now been performed. Patient compliance and acceptance have been excellent and no major complications have been observed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3104660     DOI: 10.1007/bf01728226

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  13 in total

1.  Clinical thermofiltration: initial application.

Authors:  Y Nosé; M Usami; P S Malchesky; M Emura; T Horiuchi; H Sakamoto; J W Smith
Journal:  Artif Organs       Date:  1985-11       Impact factor: 3.094

2.  Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange.

Authors:  G R Thompson; J P Miller; J L Breslow
Journal:  Br Med J (Clin Res Ed)       Date:  1985-12-14

3.  Plasma exchange for hypercholesterolaemia.

Authors:  G R Thompson
Journal:  Lancet       Date:  1981-06-06       Impact factor: 79.321

4.  Selective continuous extracorporal elimination of low-density lipoproteins with heparin at acidic pH.

Authors:  V W Armstrong; M Windisch; H Wieland; C Fuchs; J Rieger; H Köstering; K Nebendahl; F Scheler; D Seidel
Journal:  Trans Am Soc Artif Intern Organs       Date:  1983

5.  Influence of fibrin, fibrinogen and fibrinogen degradation products on cultured endothelial cells.

Authors:  K Watanabe; K Tanaka
Journal:  Atherosclerosis       Date:  1983-07       Impact factor: 5.162

6.  A new approach to the management of familial hypercholesterolaemia: Removal of plasma-cholesterol based on the principle of affinity chromatography.

Authors:  P J Lupien; S Moorjani; J Awad
Journal:  Lancet       Date:  1976-06-12       Impact factor: 79.321

7.  Regression of atherosclerosis.

Authors:  G R Thompson; N B Myant
Journal:  Atherosclerosis       Date:  1980-03       Impact factor: 5.162

8.  [Heparin dosage in chronic hemodialysis (author's transl)].

Authors:  G E Vogel; W Hansen; F L Goldmann; K F Kopp
Journal:  Med Klin       Date:  1977-10-07

9.  Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia.

Authors:  S Yokoyama; R Hayashi; M Satani; A Yamamoto
Journal:  Arteriosclerosis       Date:  1985 Nov-Dec

10.  Selective removal of apolipoprotein B-containing serum lipoproteins from blood plasma.

Authors:  W Stoffel; T Demant
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

View more
  19 in total

Review 1.  An update on LDL apheresis for nephrotic syndrome.

Authors:  Rupesh Raina; Vinod Krishnappa
Journal:  Pediatr Nephrol       Date:  2018-09-14       Impact factor: 3.714

2.  Lipoprotein-apheresis: Austrian consensus on indication and performance of treatment.

Authors:  Kurt Derfler; Sabine Steiner; Helmut Sinzinger
Journal:  Wien Klin Wochenschr       Date:  2015-07-23       Impact factor: 1.704

3.  Reduction of Lp(a) by different methods of plasma exchange.

Authors:  I Schenck; C Keller; S Hailer; G Wolfram; N Zöllner
Journal:  Klin Wochenschr       Date:  1988-12-15

4.  Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemia.

Authors:  J Thiery; C Creutzfeldt; W Creutzfeldt; A K Walli; D Seidel
Journal:  Klin Wochenschr       Date:  1990-08-17

5.  Low-density lipoprotein plasmaphaeresis with and without lovastatin in the treatment of the homozygous form of familial hypercholesterolaemia.

Authors:  J Thiery; A K Walli; G Janning; D Seidel
Journal:  Eur J Pediatr       Date:  1990-07       Impact factor: 3.183

Review 6.  Lipoprotein apheresis in the management of familial hypercholesterolaemia: historical perspective and recent advances.

Authors:  Claudia Stefanutti; Gilbert R Thompson
Journal:  Curr Atheroscler Rep       Date:  2015-01       Impact factor: 5.113

7.  Enzymatic modification of plasma low density lipoproteins in rabbits: a potential treatment for hypercholesterolemia.

Authors:  R Labeque; C J Mullon; J P Ferreira; R S Lees; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  Preparation of heparin-immobilized PVA and its adsorption for low-density lipoprotein from hyperlipemia plasma.

Authors:  Kai-Wang Ma; Li Ma; Shao-Xi Cai; Xiang Wang; Bin Liu; Zhi-Ling Xu; Xiao-Zhen Dai; Jian-Ying Yang; Ai-Hua Jing; Wan-Jun Lei
Journal:  J Mater Sci Mater Med       Date:  2008-05-13       Impact factor: 3.896

Review 9.  Interdependence of pharmacologically-induced and endothelium-mediated coronary vasodilation in antianginal therapy.

Authors:  E Bassenge; D J Stewart
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

10.  Acute and long-term effects of low-density lipoprotein apheresis on the serum concentrations of vitamins E and A.

Authors:  V W Armstrong; D Niedmann; T Eisenhauer; G Janning; H Wagner; P Schuff-Werner; D Seidel
Journal:  Klin Wochenschr       Date:  1988-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.